Profound Medical Announces Upcoming Investor Events

Core Insights - Profound Medical Corp. is a commercial-stage medical device company focused on AI-powered, MRI-guided, incision-free therapies for ablation of diseased tissue [1][3] Company Overview - Profound Medical is known for its TULSA-PRO technology, which integrates real-time MRI, AI-enhanced planning, and robotic ultrasound for prostate disease treatment [4] - The TULSA Procedure is designed to treat various prostate conditions, including low-, intermediate-, and high-risk prostate cancer, benign prostatic hyperplasia (BPH), and salvage therapy for radio-recurrent localized prostate cancer [4] - The procedure is incision-free, radiation-free, and typically completed in a single session, with patients experiencing quick recovery [4] - TULSA-PRO has received CE marking, Health Canada approval, and 510(k) clearance from the FDA [4] Additional Products - Profound Medical is also commercializing Sonalleve, a platform approved for treating uterine fibroids, adenomyosis, and pain from bone metastases, among other conditions [5] - Sonalleve has received CE marking and FDA approval under a Humanitarian Device Exemption for specific treatments and is being explored for additional applications in cancer therapy [5] Upcoming Events - The company will participate in the Lake Street Life-Sciences Invitational on February 4-5 in Scottsdale, AZ, and the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 10-11 in Snowbird, UT [6]